C. Grant

发表

Triple-negative breast cancer cell line sensitivity to englerin A identifies a new, targetable subtype

J. Beutler, Karthik Ramachandran, S. Mooberry, 2019, Breast Cancer Research and Treatment.

Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential

R. Cichewicz, S. Cai, A. L. Risinger, 2021, Cancers.

CRISPR-Cas9 Genome-Wide Knockout Screen Identifies Mechanism of Selective Activity of Dehydrofalcarinol in Mesenchymal Stem-like Triple-Negative Breast Cancer Cells.

J. Doench, Huiyun Liang, R. Cichewicz, 2020, Journal of natural products.

Microglia are implicated in the development of paclitaxel chemotherapy-associated cognitive impairment in female mice

L. Pyter, J. Otero, Kyle A. Sullivan, 2022, Brain, Behavior, and Immunity.

Mammary tumors alter the fecal bacteriome and permit enteric bacterial translocation

K. Russart, M. Bailey, L. Pyter, 2022, BMC cancer.

A novel targeted approach to delineate a role for estrogen receptor-β in ameliorating murine mammary tumor-associated neuroinflammation

K. Russart, L. Pyter, C. Grant, 2021, Endocrine.

Voluntary wheel running ameliorates select paclitaxel chemotherapy-induced sickness behaviors and associated melanocortin signaling

L. Pyter, Kyle A. Sullivan, K. Jordan, 2020, Behavioural Brain Research.

Manipulations of the gut microbiome alter chemotherapy-induced inflammation and behavioral side effects in female mice

M. Bailey, L. Pyter, B. Loman, 2021, Brain, Behavior, and Immunity.

Paclitaxel chemotherapy disrupts behavioral and molecular circadian clocks in mice

K. Obrietan, Kyle A Sullivan, C. V. Grant, 2021, Brain, Behavior, and Immunity.

Antibiotic treatment inhibits paclitaxel chemotherapy-induced activity deficits in female mice

L. Pyter, K. Jordan, C. Grant, 2023, PloS one.